ibritumomab 1
consolidation 1
cycles 1
chop 1
plus 1
radiotherapy 1
highrisk 1
limitedstage 1
aggressive 1
bcell 2
lymphoma 2
swog 1
s 1
phase 1
study 1
imexon 1
prooxidant 1
molecule 1
relapsed 1
refractory 1
nonhodgkin 1
